drugset
drugset / Trial / NCT02805972

Biology and Experience of Eating in Women With Obesity

NCT02805972 ↗

Phase 2 Completed 41 enrolled University of California, San Francisco
RandomizedCrossoverQuadruple-blindBasic science

Summary

The purpose of this study is to understand how the opioid system is involved in eating behavior.

Timeline

Start
2017-05-20
Primary completion
2018-07-25
Completion
2018-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxone Small molecule 4 mg —

Indications

obesity disorder